Karyopharm Therapeutics reported $-38433000 in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US USD 2.17B 316M
Abbvie ABBV:US USD 7.41B 84M
Amgen AMGN:US USD 2.54B 364M
AstraZeneca AZN:LN USD 2.29B 796M
Biocryst Pharmaceuticals BCRX:US USD -71466000 30.47M
Eli Lilly And LLY:US USD 2.04B 38.3M
Enanta Pharmaceuticals ENTA:US USD -29020000 2.69M
GlaxoSmithKline GSK:LN GBP 1.36B 1.07B
Johnson & Johnson JNJ:US USD 7.42B 655M
Karyopharm Therapeutics KPTI:US USD -38433000 2.15M
Macrogenics MGNX:US USD 12.8M 37.61M
Merk MRK:US USD 4.89B 560M
Mirati Therapeutics MRTX:US USD -202221000 28.91M
Nektar Therapeutics NKTR:US USD -56544000 2.66M
Novartis NOVN:VX USD 3.86B 195M
Novartis NVS:US USD 3.86B 195M
Pfizer PFE:US USD 7.38B 3.3B
Regeneron Pharmaceuticals REGN:US USD 1.63B 188.9M
Roche Holding ROG:VX 8.85B 3.26B
Sangamo Biosciences SGMO:US USD -51714000 1.41M
Takeda 4502:JP JPY 107.15B 42.6B
Tg Therapeutics TGTX:US USD -52994000 17.18M
Ultragenyx Pharmaceutical RARE:US USD -153284000 85.54M
Xencor XNCR:US USD -12457000 19.21M
YTE INCY:US USD 178.62M 401K